CN Stock MarketDetailed Quotes

600521 Zhejiang Huahai Pharmaceutical

Watchlist
  • 15.20
  • +0.16+1.06%
Market Closed Apr 19 15:00 CST
22.53BMarket Cap20.60P/E (TTM)

About Zhejiang Huahai Pharmaceutical Company

The company was founded in 1989, and its main business covers various fields such as chemicals, biopharmaceuticals, pharmaceutical packaging, and trade circulation. The company is mainly engaged in R&D, production and sales of multi-dosage generic drugs, biopharmaceuticals, innovative drugs and specialty APIs. The company's products cover cardiovascular, mental disorders, neurological, anti-infective treatment fields, etc., mainly valsartan tablets, losartan potassium tablets, irbesartan hydrochlorothiazide tablets, paroxetine hydrochloride tablets, donepezil hydrochloride tablets, levetiracetam tablets, lamotrigine controlled-release tablets, antalessan tablets, oseltamivir phosphate capsules, etc. Company Honors: National Industry-Education Integrated Enterprise, National Key High-tech Enterprise, National Innovative Enterprise, National Technological Innovation Demonstration Enterprise.

Company Profile

Short Name-A华海药业
Symbol-A600521
Company NameZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD.
Listing DateMar 4, 2003
Issue Price15.55
Shares Offered35.00M share(s)
FoundedFeb 28, 2001
Listed ExchangeSH Stock Exchange
Legal Representativebaohua chen
CEObaohua chen
Secretaryyonghua zhu
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativemin jin
Legal CounselZhejiang Tianze Law Firm
Employees5237
Phone0576-85991096
Office AddressXunqiao, Linhai City, Zhejiang Province
Zip Code317024
Registered AddressXunqiao, Linhai, Taizhou, Zhejiang
Fax0576-85016010
Email600521@huahaipharm.com
Business License330000000027652
BusinessLicensed items: pharmaceutical production; import and export of pharmaceuticals; wholesale of pharmaceuticals; health food sales (for items subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to the approval results). General projects: technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion (except for projects subject to approval according to law, independent business activities are carried out on the basis of a business license in accordance with law).

Company Executives

  • Name
  • Position
  • Salary
  • hong li
  • Chairman,directors
  • 3.12M
  • weiguang dan
  • directors
  • --
  • yonghua zhu
  • directors,Board Secretary,VP
  • 1.88M
  • yan su
  • directors
  • --
  • baohua chen
  • directors,President
  • 2.01M
  • gang li
  • Independent directors
  • 7.50K
  • xuegong wang
  • Independent directors
  • 64.50K
  • jinguo xin
  • Independent directors
  • 120.00K
  • min jin
  • Securities affairs representative
  • --
  • hugen wang
  • Chairman of the Supervisory Board,Shareholder Supervisors
  • --
  • xiuzhi tang
  • Shareholder Supervisors
  • --
  • bin he
  • VP
  • 3.14M
  • yanhua meng
  • VP
  • 1.76M
  • hui gang
  • VP
  • 2.48M
  • mei zhang
  • VP,chief financial officer
  • 1.27M
  • bo xu
  • VP
  • 1.58M
  • mi xu
  • VP
  • 1.85M
  • lihong lin
  • VP
  • 1.78M
  • sijia guo
  • VP
  • 1.97M
  • qimao chen
  • VP
  • 1.92M
  • dunyuan chen
  • VP
  • 1.81M
  • lingping hu
  • Employee supervisors
  • 514.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg